Casandra
Casandra Test Code QD24496Version 1 (DRAFT)
Performing Lab
Sequential Integrated Screen, Part 2
Clinical Use
Order TestUse
Follow-up component of the Sequential Integrated Screen after Part 1; used to complete risk assessment and integrate second-trimester maternal serum markers following an initial first-trimester screen.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Immunoassay (Multiplex Protein Panel)
Biomarkers
Targets not provided.
Result Turnaround Time
8 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Serum
Volume
Not provided
Minimum Volume
Not provided
Container
SST
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
| Frozen | 28 days |
Related Tests
Other tests from different labs that may be relevant
Serum Integrated 2
Labcorp
Sequential 2
Labcorp
Maternal Screening, Sequential, Specimen #2, Alpha Fetoprotein, hCG, Estriol, and Inhibin A
ARUP Laboratories
Serum Integrated 1
Labcorp
Maternal Serum Screening, Integrated, Specimen #2, Alpha Fetoprotein, hCG, Estriol, and Inhibin A
Mayo Clinic Lab
Sequential 1
Labcorp
Integrated 2
Labcorp
Integrated 1
Labcorp
Maternal Serum Screening, Integrated, Specimen #2, Alpha Fetoprotein, hCG, Estriol, and Inhibin A
ARUP Laboratories
Maternal Serum Screening, Integrated, Specimen #1, PAPP-A, NT
ARUP Laboratories